Shanghai Rongtai Health Technology Corporation Limited
603579.SS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.58B
Close$
Share Statistics
| Market cap | $3.58 Billion |
|---|---|
| Enterprise Value | $3.60 Billion |
| Dividend Yield | $0.50 (2.78%) |
| Earnings per Share | $0.83 |
| Beta | 0.56 |
| Outstanding Shares | 198,382,964 |
Return
| Return on Equity | 6.44% |
|---|---|
| Return on Assets | 4.53% |
| Return on Invested Capital | 4.25% |
Valuation & Multiples
| P/E Ratio | 19.79 |
|---|---|
| PEG | 769.47 |
| Price to Sales | 2.25 |
| Price to Book Ratio | 1.29 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | 29.44 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Rongtai Health Technology Corporation Limited
1,017 employees
CEO: Qi Lin Established in 1997 and headquartered in Shanghai, China, Shanghai Rongtai Health Technology Corporation Limited specializes in manufacturing and distributing a diverse array of wellness and relaxation products. Their offerings encompass...